HbA1c reductions up to 1.6 percentage points Weight trajectory: Weight loss had not plateaued by 52 weeks, indicating potential for further reduction with continued treatment Cardiometabolic: Improvements in waist circumference, blood pressure, hs-CRP, and lipid parameters Evidence level: Moderate -- well-designed phase 2 with NEJM publication, but single trial, no head-to-head comparisons
Fortunately, melanotic macules are harmless
The result looks like accelerated aging
When combined with GLP-1 medications, it can help users lose fat while preserving muscle, maintaining energy, and supporting long-term metabolic health
GENTLE EXFOLIATOR FOR DAILY USE : Combines PHA (0.1%) and Bio-Glutathione to remove dead skin cells and shield against environmental stressors